High frequency neurostimulation for pelvic symptom control
US-11045650-B2 · Jun 29, 2021 · US
US12296182B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12296182-B2 |
| Application number | US-202318540437-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 14, 2023 |
| Priority date | Sep 25, 2020 |
| Publication date | May 13, 2025 |
| Grant date | May 13, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A leadless neurostimulation device including a header unit having at least one primary electrode having a contact surface that defines an external surface on a side of the device, an outer housing that forms a side of the header unit opposite of the contact surface of the primary electrode, and a dielectric mount that receives at least a portion of the primary electrode and at least partially surrounds the primary electrode, the dielectric mount being configured to electrically insulate the primary electrode from the outer housing, the dielectric mount being received and fixed within a recessed portion of the outer housing, and a housing having a secondary electrode positioned on the same side of the leadless neurostimulation device as the primary electrode, the primary electrode and the secondary electrode being configured to transmit an electrical stimulation signal therebetween to provide electrical stimulation therapy to a tibial nerve of a patient.
Opening claim text (preview).
What is claimed is: 1. A leadless neurostimulation device comprising: a header unit comprising: a primary electrode; an outer housing; and a dielectric mount that receives at least a portion of the primary electrode and at least partially surrounds the primary electrode, the dielectric mount being configured to electrically insulate the primary electrode from the outer housing, the dielectric mount being received and fixed within a recessed portion of the outer housing; and a housing comprising a secondary electrode, wherein the primary electrode and the secondary electrode are configured to transmit an electrical stimulation signal therebetween to provide electrical stimulation therapy to a tibial nerve of a patient. 2. The leadless neurostimulation device of claim 1 , wherein the primary electrode comprises an interior surface that defines an interlocking structure with the dielectric mount. 3. The leadless neurostimulation device of claim 1 , further comprising a lead pin configured to pass through a mounting plate and connect to processing circuitry and components contained in the housing that are configured to transmit the electrical stimulation signal between the primary electrode or the secondary electrode to provide electrical stimulation therapy to the tibial nerve, wherein the primary electrode is electrically coupled to the lead pin. 4. The leadless neurostimulation device of claim 3 , wherein the primary electrode comprises Grade 2 titanium, a titanium alloy, or a Platinum-Iridium alloy, and wherein the lead pin comprises niobium. 5. The leadless neurostimulation device of claim 1 , wherein the dielectric mount defines a channel between the outer housing and the dielectric mount, the channel configured to receive a medical adhesive deposited therein to fix the outer housing to the dielectric mount. 6. The leadless neurostimulation device of claim 5 , wherein the outer housing defines a filling port in fluid communication with the channel to allow injection of the medical adhesive into the channel. 7. The leadless neurostimulation device of claim 1 , wherein the primary electrode has a contact surface that defines an external surface on a side of the leadless neurostimulation device, the contact surface being about 15 mm 2 to about 35 mm 2 . 8. The leadless neurostimulation device of claim 1 , wherein the secondary electrode is positioned on the same side of the leadless neurostimulation device as the at least one primary electrode. 9. The leadless neurostimulation device of claim 1 , wherein the primary electrode and the secondary electrode define a separation distance of about 10 mm to about 20 mm. 10. The leadless neurostimulation device of claim 1 , wherein the secondary electrode defines a contact surface area of about 40 mm 2 to about 120 mm 2 . 11. The leadless neurostimulation device of claim 1 , further comprising a dielectric coating that at least partially encapsulates the leadless neurostimulation device. 12. The leadless neurostimulation device claim 11 , wherein a boundary defined by the dielectric coating defines the secondary electrode. 13. The leadless neurostimulation device of claim 1 , wherein the device defines a total volume of about 1.5 cubic centimeters (cc) to about 3.5 cc. 14. The leadless neurostimulation device of claim 1 , further comprising a mounting plate, wherein the housing is coupled to a first side of the mounting plate and the header unit is coupled to a second side of the mounting plate. 15. A header unit for an implantable electrical stimulation device comprising: a primary electrode; an outer housing; and a dielectric mount that receives at least a portion of the primary electrode and at least partially surrounds the primary electrode, the dielectric mount being configured to electrically insulate the primary electrode from the outer housing, the dielectric mount being received and fixed within a recessed portion of the outer housing. 16. The header unit of claim 15 , wherein the primary electrode defines a substantially flat surface configured to contact patient tissue. 17. The header unit of claim 15 , wherein the primary electrode defines a partially curved surface configured to contact patient tissue. 18. The header unit of claim 15 , wherein the primary electrode defines a contact surface protruding from a plane defined by the outer housing, the contact surface configured to provide pressure against patient tissue to enhance electrical stimulation strength of the primary electrode. 19. The header unit of claim 15 , wherein the outer housing defines a perimeter edge that provides a substantially smooth surface without sharp edges to prevent patient irritation upon implantation of the header unit. 20. The header unit of claim 15 , wherein the outer housing is configured to receive and form a partial shell around the dielectric mount.
Spinal or peripheral nerve electrodes · CPC title
Casings with electrodes thereon, e.g. leadless stimulators · CPC title
Constructional arrangements, e.g. casings · CPC title
of urogenital or gastrointestinal organs, e.g. for incontinence control · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.